Evidence map›Paper›PMID 39231196›Full record

ArticlePLoS genetics2024

Temporal epigenome modulation enables efficient bacteriophage engineering and functional analysis of phage DNA modifications.

Nadiia Pozhydaieva, Franziska Anna Billau, Maik Wolfram-Schauerte, Adán Andrés Ramírez Rojas, Nicole Paczia, Daniel Schindler, Katharina Höfer

Abstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadiia PozhydaievaMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID https://orcid.org/0000-0003-2468-4235
Franziska Anna BillauMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID https://orcid.org/0009-0003-3257-456X
Maik Wolfram-SchauerteMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID https://orcid.org/0000-0001-6988-2775
Adán Andrés Ramírez RojasMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Nicole PacziaMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Daniel SchindlerMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID https://orcid.org/0000-0001-7423-6540
Katharina HöferMax Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID https://orcid.org/0000-0002-7472-9887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lytic bacteriophages hold substantial promise in medical and biotechnological applications. Therefore a comprehensive understanding of phage infection mechanisms is crucial. CRISPR-Cas systems offer a way to explore these mechanisms via site-specific phage mutagenesis. However, phages can resist Cas-mediated cleavage through extensive DNA modifications like cytosine glycosylation, hindering mutagenesis efficiency. Our study utilizes the eukaryotic enzyme NgTET to temporarily reduce phage DNA modifications, facilitating Cas nuclease cleavage and enhancing mutagenesis efficiency. This approach enables precise DNA targeting and seamless point mutation integration, exemplified by deactivating specific ADP-ribosyltransferases crucial for phage infection. Furthermore, by temporally removing DNA modifications, we elucidated the effects of these modifications on T4 phage infections without necessitating gene deletions. Our results present a strategy enabling the investigation of phage epigenome functions and streamlining the engineering of phages with cytosine DNA modifications. The described temporal modulation of the phage epigenome is valuable for synthetic biology and fundamental research to comprehend phage infection mechanisms through the generation of mutants.

Indexed as

BacteriophagesCRISPR-Cas SystemsDNA, ViralEpigenomeBacteriophage T4Escherichia coliGenetic EngineeringGenome, ViralMutagenesis, Site-DirectedDNA, Viral

Identifiers

PMID39231196
PMCPMC11404850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.